Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results
Tweet Send to a Friend
Brean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
